Global Cell Bank Creation Service Market Growth (Status and Outlook) 2024-2030

Global Cell Bank Creation Service Market Growth (Status and Outlook) 2024-2030

Product Code:1238086

Published Date: Nov 12,2024

Pages: 117

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Cell Bank Creation Service market size is projected to grow from US$ 703 million in 2024 to US$ 1462 million in 2030; it is expected to grow at a CAGR of 13.0% from 2024 to 2030.

Cell Bank Creation Service is the process of maintaining and preserving a population of cells in a culture. A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs, but can also describe the entity of stored cells itself. Cell banks often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line.

United States market for Cell Bank Creation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Cell Bank Creation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Cell Bank Creation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Cell Bank Creation Service players cover Charles River, Thermo Fisher Scientific, Lonza, WuXi Biologics, Eurofins Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “Cell Bank Creation Service Industry Forecast” looks at past sales and reviews total world Cell Bank Creation Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Cell Bank Creation Service sales for 2024 through 2030. With Cell Bank Creation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Bank Creation Service industry.

This Insight Report provides a comprehensive analysis of the global Cell Bank Creation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Bank Creation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Bank Creation Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Bank Creation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Bank Creation Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Bank Creation Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Mammalian Cell Bank
    Microbial Cell Bank
    Insect Cell Bank
    Others

Segmentation by Application:
    Biopharmaceutical Companies
    Contract Manufacturing Organizations

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Mammalian Cell Bank
    Microbial Cell Bank
    Insect Cell Bank
    Others

Segmentation by Application:
    Biopharmaceutical Companies
    Contract Manufacturing Organizations

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Charles River
    Thermo Fisher Scientific
    Lonza
    WuXi Biologics
    Eurofins Scientific
    Merck
    SGS Life Sciences
    Sartorius
    Catalent
    Goodwin Biotechnology
    Texcell
    Wuhan Canvest Biotechnology
    Takara Bio